Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2
J. Arnold, I. Barbezetto, R. Birngruber, N. M. Bressler, S. B. Bressler, G. Donati, G. E. Fish, C. J. Flaxel, E. S. Gragoudas, P. Harvey, P. K. Kaiser, J. M. Koester, H. Lewis, J. I. Lim, C. Ma, T. A. Meredith, J. W. Miller, J. Mones, S. A. Murphy, D. J. PieramiciM. J. Potter, A. Reaves, P. J. Rosenfeld, A. P. Schachat, U. Schmidt-Erfurth, L. Singerman, H. A. Strong, M. Stur, G. A. Williams
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2'. Together they form a unique fingerprint.